Lin Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lin Yang has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Junmei Xu
Department of Anesthesiology, Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China; Hunan Anesthesia Clinical Medical Care Technology Research Center, Changsha, Hunan Province, China
5 shared publications- Yaping Wang
Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, China
5 shared publications - Junmei Xu
Department of Anesthesiology, the Second XiangYa Hospital, Central South University
4 shared publications Wenjuan Zhang
Department of Laboratory, Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China
4 shared publicationsRuping Dai
Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China
3 shared publicationsWeiyun Shen
Department of Anesthesiology, Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China; Hunan Anesthesia Clinical Medical Care Technology Research Center, Changsha, Hunan Province, China
3 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1947415
Macrophage BMPRIB mediates p38-dependent inflammatory reprogramming and chemotaxis during ventilator-induced lung injury
Background: Ventilator-induced lung injury (VILI) is a major iatrogenic complication of mechanical ventilation, in which dysregulated inflammation, particularly macrophage-driven response, amplifies pulmonary damage. Although bone morphogenetic protein (BMP) signaling exhibits context-dependent effects in pulmonary disorders, whether specific BMP receptors (BMPRs) regulate macrophage function during VILI remains unknown. Methods: Mice subjected to mechanical ventilation were randomly divided into Control (intubation without ventilation), LVT (low tidal volume), and HVT (high tidal volume) groups. HVT-exposed mice received intratracheal administration of exogenous BMP4 or the BMP type I receptor antagonist LDN193189. Lung injury severity was assessed by ultrasound, macroscopic scoring, wet/dry ratio, and histopathology. Macrophage accumulation, M1/M2 polarization, interstitial-to-alveolar macrophage (IM/AM) ratio, and BMP receptor expression were evaluated. Transcriptomic profiling was performed to identify differentially expressed genes and enriched pathways. In vitro, gain- and loss-of-function experiments (overexpression and knockdown of BMPRIB) were conducted in RAW264.7 macrophages to assess cytokine/chemokine production, migration, and MAPK pathway activation. The p38 inhibitor SB202190 was used to probe downstream signaling. Results: Compared with Control and LVT groups, HVT induced time-dependent macrophage accumulation, skewed M1/M2 polarization, and a progressive elevation of the IM/AM ratio. Strikingly, HVT selectively upregulated BMPRIB in lung macrophages, while downregulating BMPRII and leaving BMPRIA unchanged. Intratracheal BMP4 exacerbated these effects, whereas LDN193189 reversed BMP4-induced macrophage accumulation, M1 polarization, IM/AM elevation, and suppressed activation of ERK, JNK, p38, and p65 signaling. Transcriptomic analysis revealed that BMP4 enriched MAPK and inflammation-related pathways, with LDN193189 co-treatment partially reversing this enrichment. In BMP4-stimulated RAW264.7 macrophages, BMPRIB overexpression enhanced, whereas BMPRIB knockdown attenuated, cytokine/chemokine production and migration. Pharmacological p38 inhibition (SB202190) abrogated BMP4-induced pro-inflammatory effects in macrophages. Conclusions: HVT-induced BMPRIB upregulation in lung macrophages allows BMP4 to activate BMPRIB-dependent p38/NF-κB p65 axis as a key mediator of macrophage-driven inflammation in VILI Targeting the BMPRIB-dependent p38/NF-κB axis may represent a novel therapeutic strategy.
- 6 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1947415
Open AccessMacrophage BMPRIB mediates p38-dependent inflammatory reprogramming and chemotaxis during ventilator-induced lung injury
Background: Ventilator-induced lung injury (VILI) is a major iatrogenic complication of mechanical ventilation, in which dysregulated inflammation, particularly macrophage-driven response, amplifies pulmonary damage. Although bone morphogenetic protein (BMP) signaling exhibits context-dependent effects in pulmonary disorders, whether specific BMP receptors (BMPRs) regulate macrophage function during VILI remains unknown. Methods: Mice subjected to mechanical ventilation were randomly divided into Control (intubation without ventilation), LVT (low tidal volume), and HVT (high tidal volume) groups. HVT-exposed mice received intratracheal administration of exogenous BMP4 or the BMP type I receptor antagonist LDN193189. Lung injury severity was assessed by ultrasound, macroscopic scoring, wet/dry ratio, and histopathology. Macrophage accumulation, M1/M2 polarization, interstitial-to-alveolar macrophage (IM/AM) ratio, and BMP receptor expression were evaluated. Transcriptomic profiling was performed to identify differentially expressed genes and enriched pathways. In vitro, gain- and loss-of-function experiments (overexpression and knockdown of BMPRIB) were conducted in RAW264.7 macrophages to assess cytokine/chemokine production, migration, and MAPK pathway activation. The p38 inhibitor SB202190 was used to probe downstream signaling. Results: Compared with Control and LVT groups, HVT induced time-dependent macrophage accumulation, skewed M1/M2 polarization, and a progressive elevation of the IM/AM ratio. Strikingly, HVT selectively upregulated BMPRIB in lung macrophages, while downregulating BMPRII and leaving BMPRIA unchanged. Intratracheal BMP4 exacerbated these effects, whereas LDN193189 reversed BMP4-induced macrophage accumulation, M1 polarization, IM/AM elevation, and suppressed activation of ERK, JNK, p38, and p65 signaling. Transcriptomic analysis revealed that BMP4 enriched MAPK and inflammation-related pathways, with LDN193189 co-treatment partially reversing this enrichment. In BMP4-stimulated RAW264.7 macrophages, BMPRIB overexpression enhanced, whereas BMPRIB knockdown attenuated, cytokine/chemokine production and migration. Pharmacological p38 inhibition (SB202190) abrogated BMP4-induced pro-inflammatory effects in macrophages. Conclusions: HVT-induced BMPRIB upregulation in lung macrophages allows BMP4 to activate BMPRIB-dependent p38/NF-κB p65 axis as a key mediator of macrophage-driven inflammation in VILI Targeting the BMPRIB-dependent p38/NF-κB axis may represent a novel therapeutic strategy.
- Open Access
WITHDRAWN: Incidence, Outcomes and Risk Factors of Cardiac Arrest Among Surgical Patients in the UK Biobank: A Population-Based Cohort Study
Withdrawal Statement: The authors have withdrawn this manuscript because upon further review, we identified errors in the experimental data that require additional validation we cannot complete at this time. We believe the most responsible course of action is to withdraw the manuscript and reconsider it for submission at a future date once these issues have been fully addressed. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Open AccessWITHDRAWN: Incidence, Outcomes and Risk Factors of Cardiac Arrest Among Surgical Patients in the UK Biobank: A Population-Based Cohort Study
Withdrawal Statement: The authors have withdrawn this manuscript because upon further review, we identified errors in the experimental data that require additional validation we cannot complete at this time. We believe the most responsible course of action is to withdraw the manuscript and reconsider it for submission at a future date once these issues have been fully addressed. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
- Open Access
- 14 April 2025
- Published by Elsevier in Life Sciences
- Vol. 372, 123641
Lipopolysaccharide amplifies the endocytosis of circulating exosomes derived from aortic dissection patients by the endothelial cells via a JMJD6 dependent manner
- 14 April 2025
- Published by Elsevier in Life Sciences
- Vol. 372, 123641
Open AccessLipopolysaccharide amplifies the endocytosis of circulating exosomes derived from aortic dissection patients by the endothelial cells via a JMJD6 dependent manner
- Open Access
- 31 March 2025
- Published by Elsevier in Life Sciences
- Vol. 371, 123594
Esketamine mitigates systemic inflammation via modulating phenotypic transformation of monocytes in patients undergoing thoracic surgery
- 31 March 2025
- Published by Elsevier in Life Sciences
- Vol. 371, 123594
Open AccessEsketamine mitigates systemic inflammation via modulating phenotypic transformation of monocytes in patients undergoing thoracic surgery
- Open Access
- 15 July 2024
- Published by Springer Nature in Research Square
BMP7 attenuates propofol induced neuron apoptosis via modulating JNK and AKT signaling
Background The aim of this study is to elucidate the protective role of bone morphogenetic protein 7 (BMP7) in mitigating the propofol-induced apoptosis on the HT-22 cells. Method Firstly, mouse hippocampal HT22 cells were treated with propofol at the concentrations of 0, 10, 50, 100uM for 12- and 24-hours to detect the propofol induced cell viability change and apoptotic effect. Secondly, BMP7 at the concentrations of 0, 20, 40, 60 ng/ml was co-incubated for 12-hrs to test whether BMP7 application could mitigate the propofol induced pro-apoptotic effect on the H22 cells. Finally, a specific BMP7 antagonist (TWSG-1) and an AKT inhibitor Akti-1/2 were applied to further investigate the downstream signals responsible for the BMP7’s protective property. In all sections, CCK-8 and LDH assay were employed to determine the cell viability and cytotoxicity; TUNEL staining was performed to investigate the apoptotic effect, and western blotting was conducted to examine the changes of the ratios of p-AKT/AKT and p-JNK/JNK. Results Firstly, propofol at the concentrations of 10, 50 and 100uM robustly induced cell viability decline, LDH release and morphological changes after 12- and 24-hours incubation. Secondly, BMP7 treatment at the concentration of 40 ng/ml statistically relieved propofol-induced cell cytotoxicity and apoptosis after 12-hours co-incubation. Thirdly, western blotting results showed that BMP7 initiated the upregulations of both p-AKT/AKT and p-JNK/JNK signals, which was antagonized by the treatment of TWSG-1 at 1ug/ml; In the meantime, Akti-1/2 prominently downregulated the ratio of p-AKT/AKT while upregulated the ratio of p-JNK/JNK. Finally, applications of both TWSG-1 and Akti-1/2 abolished BMP7 induced neuroprotective and anti-apoptotic effect. Conclusion BMP7 plays a protective role in reversing the propofol-induced apoptotic effect on HT22 cells possibly through the modulation of the downstream signals including JNK and AKT.
- 15 July 2024
- Published by Springer Nature in Research Square
Open AccessBMP7 attenuates propofol induced neuron apoptosis via modulating JNK and AKT signaling
Background The aim of this study is to elucidate the protective role of bone morphogenetic protein 7 (BMP7) in mitigating the propofol-induced apoptosis on the HT-22 cells. Method Firstly, mouse hippocampal HT22 cells were treated with propofol at the concentrations of 0, 10, 50, 100uM for 12- and 24-hours to detect the propofol induced cell viability change and apoptotic effect. Secondly, BMP7 at the concentrations of 0, 20, 40, 60 ng/ml was co-incubated for 12-hrs to test whether BMP7 application could mitigate the propofol induced pro-apoptotic effect on the H22 cells. Finally, a specific BMP7 antagonist (TWSG-1) and an AKT inhibitor Akti-1/2 were applied to further investigate the downstream signals responsible for the BMP7’s protective property. In all sections, CCK-8 and LDH assay were employed to determine the cell viability and cytotoxicity; TUNEL staining was performed to investigate the apoptotic effect, and western blotting was conducted to examine the changes of the ratios of p-AKT/AKT and p-JNK/JNK. Results Firstly, propofol at the concentrations of 10, 50 and 100uM robustly induced cell viability decline, LDH release and morphological changes after 12- and 24-hours incubation. Secondly, BMP7 treatment at the concentration of 40 ng/ml statistically relieved propofol-induced cell cytotoxicity and apoptosis after 12-hours co-incubation. Thirdly, western blotting results showed that BMP7 initiated the upregulations of both p-AKT/AKT and p-JNK/JNK signals, which was antagonized by the treatment of TWSG-1 at 1ug/ml; In the meantime, Akti-1/2 prominently downregulated the ratio of p-AKT/AKT while upregulated the ratio of p-JNK/JNK. Finally, applications of both TWSG-1 and Akti-1/2 abolished BMP7 induced neuroprotective and anti-apoptotic effect. Conclusion BMP7 plays a protective role in reversing the propofol-induced apoptotic effect on HT22 cells possibly through the modulation of the downstream signals including JNK and AKT.
- Open Access
- 10 May 2024
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 119, 836-850
Bone morphogenetic protein 4 derived from the cerebrospinal fluid in patients with postherpetic neuralgia induces allodynia via the crosstalk between microglia and astrocyte
- 10 May 2024
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 119, 836-850
Open AccessBone morphogenetic protein 4 derived from the cerebrospinal fluid in patients with postherpetic neuralgia induces allodynia via the crosstalk between microglia and astrocyte
- Open Access
- 1 January 2024
- Published by SAGE Publications in Digital Health
- Vol. 10
Application of a WeChat Mini Program to provide pharmaceutical care for cancer pain patients: A randomized controlled trial
Objective: This study aimed to develop an individual WeChat Mini Program to provide pharmaceutical care to better manage cancer pain patients and to evaluate its feasibility and the differences in analgesic efficacy, medication adherence and safety versus conventional pharmacy interventions. Methods: In this parallel randomized clinical trial, 42 cancer pain patients were equally allocated into the experimental group and the control group. The experimental group received individualized pharmaceutical care based on the “Yao Nin You Wo” WeChat Mini Program, while the control group received conventional care during the 4-week period. Main outcomes contained pain scores, medication adherence, incidences and relief rates of breakthrough pain, and incidences of adverse events. Relief rates of pain were also calculated according to pain scores. Results: At the beginning of intervention, none of the pain scores and medication adherence showed relevant differences between the two groups (all P > .05). After intervention, the experimental group had significantly lower pain scores compared to the control group ( P = .003). Breakthrough pain of both groups was alleviate; not only the incidence of breakthrough pain considerably was lower at 4 weeks than at baseline, but the relief rate of breakthrough in the experimental group was higher than that in the control group. Compared with the control group, the medication adherence rate of the experimental group was significantly improved ( P = .02). Types of adverse events that happened in experimental and groups were similar, but the total incidence of adverse events in the experimental group was lower than that in the control group. Conclusions: WeChat Mini Program is a useful and facilitative tool with the potential to improve cancer pain self-management ability in discharged patients. In addition, pharmacists could play a key role through the Mini Program to connect with patients successfully by providing personalized pharmaceutical services.
- 1 January 2024
- Published by SAGE Publications in Digital Health
- Vol. 10
Open AccessApplication of a WeChat Mini Program to provide pharmaceutical care for cancer pain patients: A randomized controlled trial
Objective: This study aimed to develop an individual WeChat Mini Program to provide pharmaceutical care to better manage cancer pain patients and to evaluate its feasibility and the differences in analgesic efficacy, medication adherence and safety versus conventional pharmacy interventions. Methods: In this parallel randomized clinical trial, 42 cancer pain patients were equally allocated into the experimental group and the control group. The experimental group received individualized pharmaceutical care based on the “Yao Nin You Wo” WeChat Mini Program, while the control group received conventional care during the 4-week period. Main outcomes contained pain scores, medication adherence, incidences and relief rates of breakthrough pain, and incidences of adverse events. Relief rates of pain were also calculated according to pain scores. Results: At the beginning of intervention, none of the pain scores and medication adherence showed relevant differences between the two groups (all P > .05). After intervention, the experimental group had significantly lower pain scores compared to the control group ( P = .003). Breakthrough pain of both groups was alleviate; not only the incidence of breakthrough pain considerably was lower at 4 weeks than at baseline, but the relief rate of breakthrough in the experimental group was higher than that in the control group. Compared with the control group, the medication adherence rate of the experimental group was significantly improved ( P = .02). Types of adverse events that happened in experimental and groups were similar, but the total incidence of adverse events in the experimental group was lower than that in the control group. Conclusions: WeChat Mini Program is a useful and facilitative tool with the potential to improve cancer pain self-management ability in discharged patients. In addition, pharmacists could play a key role through the Mini Program to connect with patients successfully by providing personalized pharmaceutical services.
- Open Access
- 15 November 2023
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 22 (12) , 3879-3892
Cerebrospinal Fluid Proteomic Profiles in Patients with Postherpetic Neuralgia
The intrinsic mechanism of postherpetic neuralgia (PHN) remains unclear. Herein, we aimed to seek the hub proteins in the cerebrospinal fluid (CSF), which display significant changes between the PHN and nonpainful patients (Control). First, the proteomic results showed that compared with the Control-CSF, there were 100 upregulated and 50 downregulated differentially expressed proteins (DEPs) in the PHN-CSF. Besides, functional analyses including gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and gene set enrichment analysis (GSEA) revealed that biological processes and pathways including complement activation, infection, coagulation, and lipid metabolism were activated, while synaptic organization was suppressed. Next, the protein-protein interaction (PPI) analysis indicated that increased PLG, F2, APOA1, APOA2, SERPINC1, and KNG1 and reduced APOE, which were all enriched in the top pathways according to the KEGG analysis, were defined as hub proteins. Finally, three of the hub proteins, such as PLG, APOA1, and APOE, were reconfirmed in a larger cohort using both enzyme-linked immunosorbent assay (ELISA) and Western blotting methods. Above all, the results indicated that PLG, APOA1, and APOE and their involved processes such as infection, inflammation, cholesterol metabolism, and coagulation shall be potential therapeutic approaches. (The raw mass spectrometry proteome data and search results have been deposited to the iProx-integrated Proteome Resources (http://www.iprox.cn) with the data set identifier IPX0007372000.).
- 15 November 2023
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 22 (12) , 3879-3892
Open AccessCerebrospinal Fluid Proteomic Profiles in Patients with Postherpetic Neuralgia
The intrinsic mechanism of postherpetic neuralgia (PHN) remains unclear. Herein, we aimed to seek the hub proteins in the cerebrospinal fluid (CSF), which display significant changes between the PHN and nonpainful patients (Control). First, the proteomic results showed that compared with the Control-CSF, there were 100 upregulated and 50 downregulated differentially expressed proteins (DEPs) in the PHN-CSF. Besides, functional analyses including gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and gene set enrichment analysis (GSEA) revealed that biological processes and pathways including complement activation, infection, coagulation, and lipid metabolism were activated, while synaptic organization was suppressed. Next, the protein-protein interaction (PPI) analysis indicated that increased PLG, F2, APOA1, APOA2, SERPINC1, and KNG1 and reduced APOE, which were all enriched in the top pathways according to the KEGG analysis, were defined as hub proteins. Finally, three of the hub proteins, such as PLG, APOA1, and APOE, were reconfirmed in a larger cohort using both enzyme-linked immunosorbent assay (ELISA) and Western blotting methods. Above all, the results indicated that PLG, APOA1, and APOE and their involved processes such as infection, inflammation, cholesterol metabolism, and coagulation shall be potential therapeutic approaches. (The raw mass spectrometry proteome data and search results have been deposited to the iProx-integrated Proteome Resources (http://www.iprox.cn) with the data set identifier IPX0007372000.).
- Open Access
- 24 October 2023
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 24 (1) , 1-15
BMP7 alleviates trigeminal neuralgia by reducing oligodendrocyte apoptosis and demyelination
Background: BMP7 has been shown to have neuroprotective effects and to alleviate demyelination. However, its role in trigeminal neuralgia (TN) has not been well investigated. The current study aims to determine whether BMP7 plays a role in demyelination, its effects on pain behaviors and mechanism of action in rats with TN. Methods: We used an infraorbital-nerve chronic-constriction injury (ION-CCI) to establish a rat model of TN. Adeno-associated viruses (AAVs) were injected into the rats to upregulate or downregulate BMP7. The mechanical withdrawal thresholds (MWT) of the injured rats were detected using Von Frey filaments. The changes in expression levels of BMP7 and oligodendrocyte (OL) markers were examined by western blotting, quantitative real-time PCR, immunofluorescence, and transmission electron microscopy. Results: The ION-CCI induced mechanical allodynia, demyelination, and loss of OLs with a reduction of BMP7. Short-hairpin RNA (shRNA)-BMP7 that inhibited BMP7 expression also caused mechanical allodynia, demyelination, and loss of OLs, and its mechanism may be OL apoptosis. Overexpressing BMP7 in the trigeminal spinal subnucleus caudalis(VC) with AAV-BMP7 relieved all three phenotypes induced by the CCI, and its mechanism may be alleviating OLs apoptosis. Two signal pathways associated with apoptosis, STAT3 and p65, were significantly downregulated in the VC after CCI and rescued by BMP7 overexpression. Conclusion: BMP7 can alleviate TN by reducing OLs apoptosis and subsequent demyelination. The mechanism behind this protection could be BMP7-mediated activation of the STAT3 and NF-κB/p65 signaling pathway and subsequent decrease in OL apoptosis. Importantly, our study presents clear evidence in support of BMP7 as a possible therapeutic target for the treatment of TN.
- 24 October 2023
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 24 (1) , 1-15
Open AccessBMP7 alleviates trigeminal neuralgia by reducing oligodendrocyte apoptosis and demyelination
Background: BMP7 has been shown to have neuroprotective effects and to alleviate demyelination. However, its role in trigeminal neuralgia (TN) has not been well investigated. The current study aims to determine whether BMP7 plays a role in demyelination, its effects on pain behaviors and mechanism of action in rats with TN. Methods: We used an infraorbital-nerve chronic-constriction injury (ION-CCI) to establish a rat model of TN. Adeno-associated viruses (AAVs) were injected into the rats to upregulate or downregulate BMP7. The mechanical withdrawal thresholds (MWT) of the injured rats were detected using Von Frey filaments. The changes in expression levels of BMP7 and oligodendrocyte (OL) markers were examined by western blotting, quantitative real-time PCR, immunofluorescence, and transmission electron microscopy. Results: The ION-CCI induced mechanical allodynia, demyelination, and loss of OLs with a reduction of BMP7. Short-hairpin RNA (shRNA)-BMP7 that inhibited BMP7 expression also caused mechanical allodynia, demyelination, and loss of OLs, and its mechanism may be OL apoptosis. Overexpressing BMP7 in the trigeminal spinal subnucleus caudalis(VC) with AAV-BMP7 relieved all three phenotypes induced by the CCI, and its mechanism may be alleviating OLs apoptosis. Two signal pathways associated with apoptosis, STAT3 and p65, were significantly downregulated in the VC after CCI and rescued by BMP7 overexpression. Conclusion: BMP7 can alleviate TN by reducing OLs apoptosis and subsequent demyelination. The mechanism behind this protection could be BMP7-mediated activation of the STAT3 and NF-κB/p65 signaling pathway and subsequent decrease in OL apoptosis. Importantly, our study presents clear evidence in support of BMP7 as a possible therapeutic target for the treatment of TN.
- Open Access
- 2 October 2023
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 62 (S1) , 99
EP01.26: Quantitative evaluation of the fetal heart in women with GDM using fetal HQ
- 2 October 2023
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 62 (S1) , 99
Open AccessEP01.26: Quantitative evaluation of the fetal heart in women with GDM using fetal HQ